| Name | cirsimaritin |
|---|---|
| Synonyms |
5,4'-dihydroxy-6,7-dimethoxyflavone
5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxychromen-4-one Flavone, 4',5-dihydroxy-6,7-dimethoxy- 6,7-Dimethoxyscutellarein Circimaritin 7-Methylcapillarisin 5-Hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-4H-chromen-4-one cirsimartin 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy-chromen-4-one Scrophulein 4H-1-Benzopyran-4-one,5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy Skrofulein 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxy- 4',5-Dihydroxy-6,7-dimethoxyflavone cirsimaritin |
| Description | Cirsimaritin binds weakly to the benzodiazepine site on GABAA receptors, with antidepressant, anxiolytic and antinociceptive activities. |
|---|---|
| Related Catalog | |
| In Vivo | Cirsimaritin significantly reduces the anxiety in mice. Cirsimaritin does not decrease by co-administration of flumazenil (2.5 mg/kg) with salvigenin, rosmanol and cirsimaritin (10 mg/kg), indicating that the high-affinity benzodiazepine binding site is not involved in the anxiolytic activity induced by these compounds[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 563.6±50.0 °C at 760 mmHg |
| Molecular Formula | C17H14O6 |
| Molecular Weight | 314.289 |
| Flash Point | 211.5±23.6 °C |
| Exact Mass | 314.079041 |
| PSA | 89.13000 |
| LogP | 1.97 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.646 |
| Storage condition | ?20°C |
| Symbol |
GHS06, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H410 |
| Precautionary Statements | P273-P301 + P310-P501 |
| Hazard Codes | T,N |
| Risk Phrases | 25-50 |
| Safety Phrases | 45-61 |
| RIDADR | UN 2811 6.1 / PGIII |
| HS Code | 2914509090 |
| Precursor 6 | |
|---|---|
| DownStream 0 | |
| HS Code | 2914509090 |
|---|---|
| Summary | HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |